BVF INC/IL - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$61,386,565
-13.8%
6,730,9830.0%1.66%
-16.6%
Q2 2023$71,213,800
-13.5%
6,730,9830.0%1.98%
-34.0%
Q1 2023$82,319,922
+74.5%
6,730,983
+77.1%
3.01%
+51.1%
Q4 2022$47,170,199
+7.8%
3,800,983
+18.6%
1.99%
+10.1%
Q3 2022$43,764,000
-25.5%
3,203,7830.0%1.81%
-36.2%
Q2 2022$58,725,000
+14.0%
3,203,7830.0%2.84%
+37.6%
Q1 2022$51,517,000
+78.3%
3,203,783
+55.2%
2.06%
+96.5%
Q4 2021$28,899,000
-5.6%
2,064,212
+26.2%
1.05%
-12.2%
Q3 2021$30,626,000
-10.2%
1,635,1120.0%1.20%
-6.5%
Q2 2021$34,092,000
-26.2%
1,635,1120.0%1.28%
-26.3%
Q1 2021$46,225,000
+13.6%
1,635,112
+31.2%
1.73%
+8.2%
Q4 2020$40,691,000
-10.8%
1,245,912
-16.3%
1.60%
-35.6%
Q3 2020$45,626,000
+0.8%
1,489,112
-46.4%
2.48%
-10.9%
Q2 2020$45,247,000
+86.8%
2,775,882
+14.0%
2.79%
+23.6%
Q1 2020$24,225,000
-11.8%
2,434,696
+21.8%
2.26%
+8.4%
Q4 2019$27,476,000
-9.4%
1,998,2760.0%2.08%
-34.6%
Q3 2019$30,314,000
-30.2%
1,998,276
-9.3%
3.18%
-32.8%
Q2 2019$43,399,000
+4.8%
2,204,119
-11.7%
4.74%
+2.3%
Q1 2019$41,395,000
+6.2%
2,495,156
-10.1%
4.64%
-9.0%
Q4 2018$38,963,000
+10.4%
2,775,156
+37.7%
5.09%
+64.3%
Q3 2018$35,277,000
-5.8%
2,015,856
-2.0%
3.10%
-15.2%
Q2 2018$37,444,000
+47.5%
2,057,346
+52.0%
3.65%
+42.0%
Q1 2018$25,385,000
+22.5%
1,353,8460.0%2.57%
+3.0%
Q4 2017$20,714,000
+2.3%
1,353,8460.0%2.50%
-3.0%
Q3 2017$20,240,0001,353,8462.57%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders